(19)
(11)EP 2 744 480 B8

(12)CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15)Correction information:
Corrected version no 1 (W1 B1)

(48)Corrigendum issued on:
26.06.2019 Bulletin 2019/26

(45)Mention of the grant of the patent:
08.05.2019 Bulletin 2019/19

(21)Application number: 12824532.1

(22)Date of filing:  16.08.2012
(51)International Patent Classification (IPC): 
A61L 27/22(2006.01)
C08J 3/075(2006.01)
A61L 27/52(2006.01)
A61K 47/42(2017.01)
(86)International application number:
PCT/US2012/051215
(87)International publication number:
WO 2013/025941 (21.02.2013 Gazette  2013/08)

(54)

LOW PROTEIN PERCENTAGE GELLING COMPOSITIONS

PROTEINARME GELIERUNGSZUSAMMENSETZUNGEN

COMPOSITIONS GÉLIFIANTES À FAIBLE CONCENTRATION EN PROTÉINES


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)Priority: 17.08.2011 US 201161524549 P

(43)Date of publication of application:
25.06.2014 Bulletin 2014/26

(73)Proprietor: Keratin Biosciences, Inc.
Lexington, MA 02421 (US)

(72)Inventors:
  • BURNETT, Luke
    Winston-Salem, North Carolina 27104 (US)
  • KNELLER, Elizabeth
    Winston-Salem, North Carolina 27103 (US)
  • TOMBLYN, Seth
    Belmont, North Carolina 28012 (US)

(74)Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)


(56)References cited: : 
WO-A2-2012/068376
US-A1- 2001 047 082
US-A1- 2005 169 963
US-A1- 2007 298 070
US-B1- 6 316 598
US-A- 5 932 552
US-A1- 2004 076 599
US-A1- 2007 166 348
US-A1- 2008 274 165
  
  • R. C. DE GUZMAN ET AL.: 'Machanical and biological properties of keratose biomaterilas' BIOMATERIALS vol. 32, no. ISS.32, 11 August 2011, pages 8205 - 8217, XP028277130
  • P. HILL ET AL.: 'Some properties of keratin biomaterilas: Kerateines' BIOMATERIALS vol. 31, no. ISS.4, 12 October 2009, pages 585 - 593, XP026762067
  • J. M. SAUL ET AL.: 'Keratin hydrogels support the sustained release of bioactive ciprofloxacin' JOURNAL OF BIOMEDICAL MATERIALS RESEARCH vol. 98A, no. ISS.4, 16 June 2011, page 548, XP055144637
  
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).